TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Saad, A. F. AU - Hu, W. AU - Sood, A. K. PY - 2010 DA - 2010// TI - Microenvironment and pathogenesis of epithelial ovarian cancer JO - Horm Cancer VL - 1 UR - https://doi.org/10.1007/s12672-010-0054-2 DO - 10.1007/s12672-010-0054-2 ID - Saad2010 ER - TY - JOUR AU - Correia, A. L. AU - Bissell, M. J. PY - 2012 DA - 2012// TI - The tumor microenvironment is a dominant force in multidrug resistance JO - Drug Resist Updat VL - 15 UR - https://doi.org/10.1016/j.drup.2012.01.006 DO - 10.1016/j.drup.2012.01.006 ID - Correia2012 ER - TY - JOUR AU - Nik, N. N. AU - Vang, R. AU - Shih Ie, M. AU - Kurman, R. J. PY - 2014 DA - 2014// TI - Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma JO - Annu Rev Pathol VL - 9 UR - https://doi.org/10.1146/annurev-pathol-020712-163949 DO - 10.1146/annurev-pathol-020712-163949 ID - Nik2014 ER - TY - JOUR AU - Ween, M. P. AU - Lokman, N. A. AU - Hoffmann, P. AU - Rodgers, R. J. AU - Ricciardelli, C. AU - Oehler, M. K. PY - 2011 DA - 2011// TI - Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells JO - Int J Cancer VL - 128 UR - https://doi.org/10.1002/ijc.25494 DO - 10.1002/ijc.25494 ID - Ween2011 ER - TY - JOUR AU - Lokman, N. A. AU - Ween, M. P. AU - Oehler, M. K. AU - Ricciardelli, C. PY - 2011 DA - 2011// TI - The role of annexin A2 in tumorigenesis and cancer progression JO - Cancer Microenviron VL - 4 UR - https://doi.org/10.1007/s12307-011-0064-9 DO - 10.1007/s12307-011-0064-9 ID - Lokman2011 ER - TY - JOUR AU - Lokman, N. A. AU - Elder, A. S. AU - Ween, M. P. AU - Pyragius, C. E. AU - Hoffmann, P. AU - Oehler, M. K. PY - 2013 DA - 2013// TI - Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis JO - Oncotarget VL - 4 UR - https://doi.org/10.18632/oncotarget.1122 DO - 10.18632/oncotarget.1122 ID - Lokman2013 ER - TY - JOUR AU - Lokman, N. A. AU - Pyragius, C. E. AU - Ruszkiewicz, A. AU - Oehler, M. K. AU - Ricciardelli, C. PY - 2016 DA - 2016// TI - Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome JO - Transl Res VL - 171 UR - https://doi.org/10.1016/j.trsl.2016.02.002 DO - 10.1016/j.trsl.2016.02.002 ID - Lokman2016 ER - TY - JOUR AU - Bharadwaj, A. AU - Bydoun, M. AU - Holloway, R. AU - Waisman, D. PY - 2013 DA - 2013// TI - Annexin A2 heterotetramer: structure and function JO - Int J Mol Sci VL - 14 UR - https://doi.org/10.3390/ijms14036259 DO - 10.3390/ijms14036259 ID - Bharadwaj2013 ER - TY - JOUR AU - Waisman, D. M. PY - 1995 DA - 1995// TI - Annexin II tetramer: structure and function JO - Mol Cell Biochem VL - 149–150 UR - https://doi.org/10.1007/BF01076592 DO - 10.1007/BF01076592 ID - Waisman1995 ER - TY - JOUR AU - Hedhli, N. AU - Falcone, D. J. AU - Huang, B. AU - Cesarman-Maus, G. AU - Kraemer, R. AU - Zhai, H. PY - 2012 DA - 2012// TI - The annexin A2/S100A10 system in health and disease: emerging paradigms JO - J Biomed Biotechnol VL - 2012 UR - https://doi.org/10.1155/2012/406273 DO - 10.1155/2012/406273 ID - Hedhli2012 ER - TY - JOUR AU - Myrvang, H. K. AU - Guo, X. AU - Li, C. AU - Dekker, L. V. PY - 2013 DA - 2013// TI - Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells JO - FEBS Lett VL - 587 UR - https://doi.org/10.1016/j.febslet.2013.08.012 DO - 10.1016/j.febslet.2013.08.012 ID - Myrvang2013 ER - TY - JOUR AU - Bydoun, M. AU - Waisman, D. M. PY - 2014 DA - 2014// TI - On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity JO - Future Oncol VL - 10 UR - https://doi.org/10.2217/fon.14.163 DO - 10.2217/fon.14.163 ID - Bydoun2014 ER - TY - JOUR AU - Diaz, V. M. AU - Hurtado, M. AU - Thomson, T. M. AU - Reventos, J. AU - Paciucci, R. PY - 2004 DA - 2004// TI - Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro JO - Gut VL - 53 UR - https://doi.org/10.1136/gut.2003.026831 DO - 10.1136/gut.2003.026831 ID - Diaz2004 ER - TY - JOUR AU - Sharma, M. AU - Ownbey, R. T. AU - Sharma, M. C. PY - 2010 DA - 2010// TI - Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation JO - Exp Mol Pathol VL - 88 UR - https://doi.org/10.1016/j.yexmp.2010.01.001 DO - 10.1016/j.yexmp.2010.01.001 ID - Sharma2010 ER - TY - JOUR AU - Degos, L. AU - Wang, Z. Y. PY - 2001 DA - 2001// TI - All trans retinoic acid in acute promyelocytic leukemia JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204763 DO - 10.1038/sj.onc.1204763 ID - Degos2001 ER - TY - JOUR AU - Menell, J. S. AU - Cesarman, G. M. AU - Jacovina, A. T. AU - McLaughlin, M. A. AU - Lev, E. A. AU - Hajjar, K. A. PY - 1999 DA - 1999// TI - Annexin II and bleeding in acute promyelocytic leukemia JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199904013401303 DO - 10.1056/NEJM199904013401303 ID - Menell1999 ER - TY - JOUR AU - Tang, X. H. AU - Gudas, L. J. PY - 2011 DA - 2011// TI - Retinoids, retinoic acid receptors, and cancer JO - Annu Rev Pathol VL - 6 UR - https://doi.org/10.1146/annurev-pathol-011110-130303 DO - 10.1146/annurev-pathol-011110-130303 ID - Tang2011 ER - TY - JOUR AU - Lo-Coco, F. AU - Avvisati, G. AU - Vignetti, M. AU - Thiede, C. AU - Orlando, S. M. AU - Iacobelli, S. PY - 2013 DA - 2013// TI - Retinoic acid and arsenic trioxide for acute promyelocytic leukemia JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1300874 DO - 10.1056/NEJMoa1300874 ID - Lo-Coco2013 ER - TY - JOUR AU - O'Connell, P. A. AU - Madureira, P. A. AU - Berman, J. N. AU - Liwski, R. S. AU - Waisman, D. M. PY - 2011 DA - 2011// TI - Regulation of S100A10 by the PML-RAR-alpha oncoprotein JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-07-298851 DO - 10.1182/blood-2010-07-298851 ID - O'Connell2011 ER - TY - JOUR AU - Olwill, S. A. AU - McGlynn, H. AU - Gilmore, W. S. AU - Alexander, H. D. PY - 2005 DA - 2005// TI - All-trans retinoic acid-induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia JO - Br J Haematol VL - 131 UR - https://doi.org/10.1111/j.1365-2141.2005.05750.x DO - 10.1111/j.1365-2141.2005.05750.x ID - Olwill2005 ER - TY - JOUR AU - Zhang, X. AU - Zhou, H. AU - Wang, J. AU - Yang, L. AU - Hu, Y. AU - Shen, G. PY - 2002 DA - 2002// TI - Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator JO - Thromb Res VL - 106 UR - https://doi.org/10.1016/S0049-3848(02)00075-0 DO - 10.1016/S0049-3848(02)00075-0 ID - Zhang2002 ER - TY - JOUR AU - Garattini, E. AU - Bolis, M. AU - Garattini, S. K. AU - Fratelli, M. AU - Centritto, F. AU - Paroni, G. PY - 2014 DA - 2014// TI - Retinoids and breast cancer: from basic studies to the clinic and back again JO - Cancer Treat Rev VL - 40 UR - https://doi.org/10.1016/j.ctrv.2014.01.001 DO - 10.1016/j.ctrv.2014.01.001 ID - Garattini2014 ER - TY - JOUR AU - Masi, A. AU - Leboffe, L. AU - Marinis, E. AU - Pagano, F. AU - Cicconi, L. AU - Rochette-Egly, C. PY - 2015 DA - 2015// TI - Retinoic acid receptors: from molecular mechanisms to cancer therapy JO - Mol Asp Med VL - 41 UR - https://doi.org/10.1016/j.mam.2014.12.003 DO - 10.1016/j.mam.2014.12.003 ID - Masi2015 ER - TY - JOUR AU - Bolis, M. AU - Garattini, E. AU - Paroni, G. AU - Zanetti, A. AU - Kurosaki, M. AU - Castrignano, T. PY - 2017 DA - 2017// TI - Network-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid JO - Ann Oncol VL - 28 ID - Bolis2017 ER - TY - JOUR AU - Krupitza, G. AU - Hulla, W. AU - Harant, H. AU - Dittrich, E. AU - Kallay, E. AU - Huber, H. PY - 1995 DA - 1995// TI - Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation JO - Int J Cancer VL - 61 UR - https://doi.org/10.1002/ijc.2910610511 DO - 10.1002/ijc.2910610511 ID - Krupitza1995 ER - TY - JOUR AU - Wu, S. AU - Donigan, A. AU - Platsoucas, C. D. AU - Jung, W. AU - Soprano, D. R. AU - Soprano, K. J. PY - 1997 DA - 1997// TI - All-trans-retinoic acid blocks cell cycle progression of human ovarian adenocarcinoma cells at late G1 JO - Exp Cell Res VL - 232 UR - https://doi.org/10.1006/excr.1997.3495 DO - 10.1006/excr.1997.3495 ID - Wu1997 ER - TY - JOUR AU - Karabulut, B. AU - Karaca, B. AU - Varol, U. AU - Muslu, U. AU - Cakar, B. AU - Atmaca, H. PY - 2010 DA - 2010// TI - Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer JO - J Exp Clin Cancer Res VL - 29 UR - https://doi.org/10.1186/1756-9966-29-102 DO - 10.1186/1756-9966-29-102 ID - Karabulut2010 ER - TY - JOUR AU - Purev, E. AU - Soprano, D. R. AU - Soprano, K. J. PY - 2011 DA - 2011// TI - PP2A interaction with Rb2/p130 mediates translocation of Rb2/p130 into the nucleus in all-trans retinoic acid-treated ovarian carcinoma cells JO - J Cell Physiol VL - 226 UR - https://doi.org/10.1002/jcp.22418 DO - 10.1002/jcp.22418 ID - Purev2011 ER - TY - JOUR AU - Soprano, K. J. AU - Purev, E. AU - Vuocolo, S. AU - Soprano, D. R. PY - 2006 DA - 2006// TI - Rb2/p130 and protein phosphatase 2A: key mediators of ovarian carcinoma cell growth suppression by all-trans retinoic acid JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209679 DO - 10.1038/sj.onc.1209679 ID - Soprano2006 ER - TY - JOUR AU - Ricciardelli, C. AU - Lokman, N. A. AU - Cheruvu, S. AU - Tan, I. A. AU - Ween, M. P. AU - Pyragius, C. E. PY - 2015 DA - 2015// TI - Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation JO - Clin Exp Metastasis VL - 32 UR - https://doi.org/10.1007/s10585-015-9718-1 DO - 10.1007/s10585-015-9718-1 ID - Ricciardelli2015 ER - TY - JOUR AU - Ricciardelli, C. AU - Ween, M. P. AU - Lokman, N. A. AU - Tan, I. A. AU - Pyragius, C. E. AU - Oehler, M. K. PY - 2013 DA - 2013// TI - Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-476 DO - 10.1186/1471-2407-13-476 ID - Ricciardelli2013 ER - TY - JOUR AU - Ricciardelli, C. AU - Lokman, N. A. AU - Sabit, I. AU - Gunasegaran, K. AU - Bonner, W. M. AU - Pyragius, C. E. PY - 2018 DA - 2018// TI - Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics JO - Cancer Lett VL - 421 UR - https://doi.org/10.1016/j.canlet.2018.02.006 DO - 10.1016/j.canlet.2018.02.006 ID - Ricciardelli2018 ER - TY - JOUR AU - Bianco-Miotto, T. AU - Chiam, K. AU - Buchanan, G. AU - Jindal, S. AU - Day, T. K. AU - Thomas, M. PY - 2010 DA - 2010// TI - Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development JO - Cancer Epidemiol Biomark Prev VL - 19 UR - https://doi.org/10.1158/1055-9965.EPI-10-0555 DO - 10.1158/1055-9965.EPI-10-0555 ID - Bianco-Miotto2010 ER - TY - JOUR AU - Schug, T. T. AU - Berry, D. C. AU - Shaw, N. S. AU - Travis, S. N. AU - Noy, N. PY - 2007 DA - 2007// TI - Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors JO - Cell VL - 129 UR - https://doi.org/10.1016/j.cell.2007.02.050 DO - 10.1016/j.cell.2007.02.050 ID - Schug2007 ER - TY - JOUR AU - Schenk, T. AU - Stengel, S. AU - Zelent, A. PY - 2014 DA - 2014// TI - Unlocking the potential of retinoic acid in anticancer therapy JO - Br J Cancer VL - 111 UR - https://doi.org/10.1038/bjc.2014.412 DO - 10.1038/bjc.2014.412 ID - Schenk2014 ER - TY - JOUR AU - Centritto, F. AU - Paroni, G. AU - Bolis, M. AU - Garattini, S. K. AU - Kurosaki, M. AU - Barzago, M. M. PY - 2015 DA - 2015// TI - Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: luminal phenotype and RARalpha expression JO - EMBO Mol Med VL - 7 UR - https://doi.org/10.15252/emmm.201404670 DO - 10.15252/emmm.201404670 ID - Centritto2015 ER - TY - JOUR AU - Ravikumar, S. AU - Perez-Liz, G. AU - Vale, L. AU - Soprano, D. R. AU - Soprano, K. J. PY - 2007 DA - 2007// TI - Insulin receptor substrate-1 is an important mediator of ovarian cancer cell growth suppression by all-trans retinoic acid JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2088 DO - 10.1158/0008-5472.CAN-07-2088 ID - Ravikumar2007 ER - TY - JOUR AU - Coscia, F. AU - Watters, K. M. AU - Curtis, M. AU - Eckert, M. A. AU - Chiang, C. Y. AU - Tyanova, S. PY - 2016 DA - 2016// TI - Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms12645 DO - 10.1038/ncomms12645 ID - Coscia2016 ER - TY - JOUR AU - Narvekar, M. AU - Xue, H. Y. AU - Tran, N. T. AU - Mikhael, M. AU - Wong, H. L. PY - 2014 DA - 2014// TI - A new nanostructured carrier design including oil to enhance the pharmaceutical properties of retinoid therapy and its therapeutic effects on chemo-resistant ovarian cancer JO - Eur J Pharm Biopharm VL - 88 UR - https://doi.org/10.1016/j.ejpb.2014.04.014 DO - 10.1016/j.ejpb.2014.04.014 ID - Narvekar2014 ER - TY - JOUR AU - Young, M. J. AU - Wu, Y. H. AU - Chiu, W. T. AU - Weng, T. Y. AU - Huang, Y. F. AU - Chou, C. Y. PY - 2015 DA - 2015// TI - All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells JO - Carcinogenesis VL - 36 UR - https://doi.org/10.1093/carcin/bgv018 DO - 10.1093/carcin/bgv018 ID - Young2015 ER - TY - JOUR AU - Gladwin, M. T. AU - Yao, X. L. AU - Cowan, M. AU - Huang, X. L. AU - Schneider, R. AU - Grant, L. R. PY - 2000 DA - 2000// TI - Retinoic acid reduces p11 protein levels in bronchial epithelial cells by a posttranslational mechanism JO - Am J Physiol Lung Cell Mol Physiol VL - 279 UR - https://doi.org/10.1152/ajplung.2000.279.6.L1103 DO - 10.1152/ajplung.2000.279.6.L1103 ID - Gladwin2000 ER - TY - JOUR AU - Holloway, R. W. AU - Thomas, M. L. AU - Cohen, A. M. AU - Bharadwaj, A. G. AU - Rahman, M. AU - Marcato, P. PY - 2018 DA - 2018// TI - Regulation of cell surface protease receptor S100A10 by retinoic acid therapy in acute promyelocytic leukemia (APL)() JO - Cell Death Dis VL - 9 UR - https://doi.org/10.1038/s41419-018-0954-6 DO - 10.1038/s41419-018-0954-6 ID - Holloway2018 ER - TY - JOUR AU - Zanetti, A. AU - Affatato, R. AU - Centritto, F. AU - Fratelli, M. AU - Kurosaki, M. AU - Barzago, M. M. PY - 2015 DA - 2015// TI - All-trans-retinoic acid modulates the plasticity and inhibits the motility of breast Cancer cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFbeta) JO - J Biol Chem VL - 290 UR - https://doi.org/10.1074/jbc.M115.638510 DO - 10.1074/jbc.M115.638510 ID - Zanetti2015 ER -